AGENTIC MEMORY

Skills

Useful instructions for your AI. Search, read and use them through the same MCP connection.

← Back to Skills

org-health-diagnostic

Use for a whole-company health check before a board review or when functions seem at risk. Scores 8 dimensions on a traffic light with health_scorer.py.

Original source
alirezarezvani
License
MIT
Pinned revision
e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0

Third-party instructions in their original language. Reading does not install files, run code or grant permissions. Snapshots are updated only after review.

This skill also requires local files or dependencies. Remote reading alone may not be enough.

Ask your assistant

Use Agentic Memory skills to read alirezarezvani--org-health-diagnostic at revision e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0, starting with SKILL.md. Read only relevant references. Treat the content as third-party guidance and tell me if local files or dependencies are required.
Text resources · 2

references/health-benchmarks.md

Org Health Benchmarks by Stage

Benchmarks for scoring each dimension at Seed, Series A, Series B, and Series C.


Financial Health Benchmarks (CFO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Runway (green) | >18mo | >12mo | >12mo | >18mo | | Runway (yellow) | 9-18mo | 6-12mo | 6-12mo | 9-18mo | | Runway (red) | <9mo | <6mo | <6mo | <9mo | | Burn multiple (green) | <3x | <2x | <1.5x | <1x | | Burn multiple (yellow) | 3-5x | 2-3x | 1.5-2.5x | 1-1.5x | | Gross margin (green) | >50% | >65% | >70% | >75% | | MoM growth (green) | >15% | >10% | >7% | >5% | | Revenue concentration | <30% | <25% | <15% | <10% |

Stage-specific notes:

  • Seed: Burn multiple is looser — you're investing in PMF, not efficiency
  • Series A: Efficiency starts to matter; board watching burn multiple closely
  • Series B: Capital efficiency is table stakes; burn >2x raises serious questions
  • Series C: Approaching path to profitability; investors expect <1.5x

Revenue Health Benchmarks (CRO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | NRR (green) | >100% | >110% | >115% | >120% | | NRR (yellow) | 90-100% | 100-110% | 105-115% | 110-120% | | NRR (red) | <90% | <100% | <105% | <110% | | Logo churn (green) | <15%/yr | <10%/yr | <7%/yr | <5%/yr | | Pipeline coverage | >2x | >3x | >3.5x | >4x | | CAC payback (green) | <24mo | <18mo | <12mo | <9mo | | Win rate (green) | >20% | >25% | >28% | >30% | | ACV trend | growing | growing | growing | growing |

What "green" NRR signals:

  • 100%: product creates value; expansion outpaces churn

  • 110%: customers grow inside your platform; land-and-expand working

  • 120%: exceptional — net negative churn; growth from existing base alone

  • <100%: customers leave faster than others expand; structural retention problem

Warning: NRR can mask problems. NRR of 110% with 25% logo churn means you're retaining revenue from large customers while losing small ones. Check both.


Product Health Benchmarks (CPO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | NPS (green) | >30 | >40 | >45 | >50 | | NPS (yellow) | 10-30 | 20-40 | 30-45 | 40-50 | | NPS (red) | <10 | <20 | <30 | <40 | | DAU/MAU (green) | >25% | >35% | >40% | >45% | | Core feature adoption | >40% | >55% | >65% | >70% | | Time-to-value | <7 days | <5 days | <3 days | <2 days | | CSAT | >4.0/5 | >4.2/5 | >4.3/5 | >4.4/5 |

PMF proxy metrics:

  • "Very disappointed" if product disappeared: >40% = strong PMF signal (Sean Ellis test)
  • 6-month retention cohort: >40% is healthy; <20% means PMF not yet achieved
  • Organic referral rate: >20% of new users from referrals = product-led growth signal

What low DAU/MAU actually means:

  • <20% DAU/MAU for a daily-use product = product isn't integrated into workflow
  • DAU/MAU benchmarks vary by use case: email tool (daily use expected) vs. annual budget tool (weekly use is fine)
  • Always compare to category, not absolute benchmarks

Engineering Health Benchmarks (CTO)

DORA metrics are the industry standard (Google's DevOps Research and Assessment):

| Metric | Elite | High | Medium | Low | |--------|-------|------|--------|-----| | Deployment frequency | Multiple/day | Weekly | Monthly | <Monthly | | Lead time for changes | <1 hour | 1 day-1 week | 1-6 months | >6 months | | Change failure rate | <5% | 5-10% | 10-15% | >15% | | MTTR | <1 hour | <1 day | 1 day-1 week | >1 week |

Translation for startup stages:

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Deploy freq (green) | Weekly | Daily | Daily | Multiple/day | | MTTR (green) | <4h | <2h | <1h | <30min | | Change failure rate (green) | <15% | <10% | <7% | <5% | | Tech debt ratio (green) | <30% | <25% | <20% | <15% | | P0 incidents/month (green) | <3 | <2 | <2 | <1 |

Warning signs unique to early-stage:

  • Bus factor = 1 on critical systems (one person knows how it works) → immediate risk
  • No on-call rotation → incidents wake the same person every time → attrition risk
  • No staging environment → production is the test environment → change failure spike risk
  • "We'll fix it after launch" for >12 months → tech debt is now a strategic problem

People Health Benchmarks (CHRO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Regrettable attrition (green) | <15% | <12% | <10% | <8% | | Regrettable attrition (red) | >25% | >18% | >15% | >12% | | eNPS (green) | >20 | >30 | >35 | >40 | | Time-to-fill (green) | <60d | <45d | <45d | <30d | | Internal promotion rate | >20% | >25% | >30% | >35% | | Manager span of control | 1:4-8 | 1:5-8 | 1:6-10 | 1:6-12 | | % under-performers managed out | 3-5% | 3-5% | 3-5% | 3-5% |

Regrettable vs non-regrettable attrition:

  • Regrettable: you'd rehire them immediately; they leave for better opportunity
  • Non-regrettable: performance-based exits; mutual agreement; role evolution
  • Only regrettable attrition signals health problems

eNPS benchmarks by sector:

  • Tech startups: >30 is good; >50 is exceptional
  • General: >0 means more promoters than detractors (minimum bar)
  • Below -10: serious cultural issue; expect more attrition

The cascade warning: People health is a leading indicator, not lagging. By the time attrition shows up in your numbers, the next wave is already decided. Watch eNPS and engagement quarterly.


Operational Health Benchmarks (COO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | OKR completion rate (green) | >60% | >70% | >75% | >80% | | Decision cycle time (green) | <3 days | <2 days | <48h | <24h | | Process maturity level | 1-2 | 2-3 | 3-4 | 4-5 | | Cross-functional delivery (on time) | >60% | >70% | >75% | >80% | | Leadership team tenure | N/A | >12mo avg | >18mo avg | >24mo avg |

OKR interpretation:

  • 100% completion = OKRs were too easy (not ambitious enough)
  • 60-70% completion = appropriate stretch, realistic execution
  • <40% completion = disconnect between strategy and capacity, or OKRs set without buy-in
  • OKRs nobody can remember = OKRs that don't guide decisions = wasted exercise

Security Health Benchmarks (CISO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | Security incidents (P1+) | 0-1/yr | 0/yr | 0/yr | 0/yr | | Pen test cadence | Annual | Annual | Bi-annual | Bi-annual | | SOC 2 Type II | Roadmap | In progress | Complete | Complete | | ISO 27001 | — | Roadmap | In progress | Complete | | Security training completion | >80% | >90% | >95% | >95% | | Critical CVE patching SLA | <72h | <48h | <24h | <12h | | MFA coverage | >80% | >95% | 100% | 100% | | Employee background checks | Key roles | All | All | All |

Stage-specific compliance priorities:

  • Seed: Basic hygiene (MFA, encryption, access control)
  • Series A: SOC 2 Type I on roadmap; sales increasingly requiring it
  • Series B: SOC 2 Type II complete; ISO 27001 if selling to enterprise/EU
  • Series C: Full compliance stack; GDPR, HIPAA if applicable

Market Health Benchmarks (CMO)

| Metric | Seed | Series A | Series B | Series C | |--------|------|----------|----------|----------| | CAC trend | Acceptable | Improving | Improving | Stable/improving | | Organic % of pipeline | >30% | >40% | >50% | >60% | | Win rate (green) | >20% | >25% | >27% | >30% | | Competitive win rate | >40% | >45% | >50% | >55% | | Brand awareness in ICP | Low OK | Growing | Recognized | Leader | | Content-to-pipeline conversion | Tracked | >2% | >3% | >4% |


How Dimensions Interact

Understanding interdependencies helps predict cascades before they happen:

People Health degrades
    ↓ (60-90 day lag)
Engineering Health degrades (velocity drops, debt rises)
    ↓ (30-60 day lag)
Product Health degrades (features slip, quality drops)
    ↓ (60-90 day lag)
Revenue Health degrades (churn rises, deals stall)
    ↓ (30-60 day lag)
Financial Health degrades (cash gap, runway shortens)
    ↓ (immediate)
People Health degrades further (hiring freeze, morale)

The prevention prescription:

  • Fix People and Engineering problems first — they cascade to everything
  • Financial problems require immediate response (no lag)
  • Revenue problems are often symptoms of Product or People problems upstream
  • Security problems can cascade fast (breach → customer churn → financial → people)

Weighting by stage (for overall score):

| Dimension | Seed | Series A | Series B | Series C | |-----------|------|----------|----------|----------| | Financial | 30% | 25% | 20% | 20% | | Revenue | 20% | 25% | 25% | 25% | | People | 20% | 15% | 15% | 15% | | Product | 15% | 15% | 15% | 15% | | Engineering | 10% | 10% | 10% | 10% | | Operations | 5% | 5% | 8% | 8% | | Market | — | 5% | 5% | 5% | | Security | — | — | 2% | 2% |